JP2008504224A - Ｅｃｔ２のプレクストリン相同ドメインを含むポリペプチド、及びホスファチジルイノシトールに対するその結合特異性 - Google Patents

Ｅｃｔ２のプレクストリン相同ドメインを含むポリペプチド、及びホスファチジルイノシトールに対するその結合特異性 Download PDF

Info

Publication number
JP2008504224A
JP2008504224A JP2006551934A JP2006551934A JP2008504224A JP 2008504224 A JP2008504224 A JP 2008504224A JP 2006551934 A JP2006551934 A JP 2006551934A JP 2006551934 A JP2006551934 A JP 2006551934A JP 2008504224 A JP2008504224 A JP 2008504224A
Authority
JP
Japan
Prior art keywords
ect2
domain
polypeptide
binding
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551934A
Other languages
English (en)
Japanese (ja)
Inventor
ロジャー スレイ
グレアム トムソン
Original Assignee
サイクラセル リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイクラセル リミテッド filed Critical サイクラセル リミテッド
Publication of JP2008504224A publication Critical patent/JP2008504224A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006551934A 2004-02-10 2005-02-09 Ｅｃｔ２のプレクストリン相同ドメインを含むポリペプチド、及びホスファチジルイノシトールに対するその結合特異性 Withdrawn JP2008504224A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0402904A GB0402904D0 (en) 2004-02-10 2004-02-10 Polypeptide
PCT/GB2005/000439 WO2005077975A2 (fr) 2004-02-10 2005-02-09 Polypeptide

Publications (1)

Publication Number Publication Date
JP2008504224A true JP2008504224A (ja) 2008-02-14

Family

ID=32011637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551934A Withdrawn JP2008504224A (ja) 2004-02-10 2005-02-09 Ｅｃｔ２のプレクストリン相同ドメインを含むポリペプチド、及びホスファチジルイノシトールに対するその結合特異性

Country Status (4)

Country Link
EP (1) EP1713826A2 (fr)
JP (1) JP2008504224A (fr)
GB (1) GB0402904D0 (fr)
WO (1) WO2005077975A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2019026883A1 (ja) * 2017-07-31 2020-05-28 住友化学株式会社 大環状化合物の製造方法
JP2021112189A (ja) * 2015-05-06 2021-08-05 イマティクス バイオテクノロジーズ ゲーエムベーハー 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ306732B6 (cs) 2013-12-19 2017-05-31 Zentiva, K.S. Způsob přípravy bezvodé polymorfní formy N-6 Dasatinibu

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515109B1 (en) * 2000-10-12 2003-02-04 Exelixis, Inc. Human ECT2 polypeptide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021112189A (ja) * 2015-05-06 2021-08-05 イマティクス バイオテクノロジーズ ゲーエムベーハー 結腸直腸がん（ｃｒｃ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチドとそのスキャフォールドとの組み合わせ
JPWO2019026883A1 (ja) * 2017-07-31 2020-05-28 住友化学株式会社 大環状化合物の製造方法
JP7150728B2 (ja) 2017-07-31 2022-10-11 住友化学株式会社 大環状化合物の製造方法

Also Published As

Publication number Publication date
WO2005077975A3 (fr) 2005-11-10
EP1713826A2 (fr) 2006-10-25
WO2005077975A2 (fr) 2005-08-25
GB0402904D0 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
US6630297B2 (en) Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
AU2002211665A1 (en) Human Ect2 and methods of use
US20040101879A1 (en) Srebp pathway modulation through targeting hisrs
WO2002055663A2 (fr) Modulation du passage srebp par des hisrs cibles
JP2008504224A (ja) Ｅｃｔ２のプレクストリン相同ドメインを含むポリペプチド、及びホスファチジルイノシトールに対するその結合特異性
US20050170343A1 (en) Modulating insulin receptor signaling
US8809500B2 (en) Complexes comprising mammalian raptor polypeptide and mammalian mTOR polypeptide
EP1860199B1 (fr) Modulation de signal de récépteur d'insuline
US20030138832A1 (en) Modulating insulin receptor signaling through targeting FACL
KR20010085407A (ko) Ｔｐｌ-２/ｃｏｔ 키나제 및 그의 사용 방법
WO2003033656A2 (fr) Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation
US20060088829A1 (en) Minrs as modifiers of insulin receptor signaling and methods of use
Pirone The role of SPECs in CDC42 signaling pathways
AU2003215007A1 (en) MINRs as modifiers of insulin receptor signaling and methods of use
WO2003073063A2 (fr) Modulation de la signalisation du recepteur de l'insuline par ciblage de helic1
Park Characterization of PRAS40, a novel Akt substrate
Du Cloning and characterization of protein phosphatase methylesterase-1 (PME-1)
WO2003066811A2 (fr) Genes msrebp utilises en tant que modificateurs de la voie des proteines srebp, et procedes d'utilisation associes
JP2008522616A (ja) キナーゼハスピンに基づく組成物および方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071122

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080627